Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultra-early tranexamic acid after subarachnoid hemorrhage
2012-000343-26Phase 3Completed
- Sponsor
- Academic Medical Center
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of tranexamic acid in subarachnoid hemorrhage (SAH) (2 arms), sponsored by Academic Medical Center. Primary endpoint: Favourable functional outcome at 6 months. Started Aug 2012; status: completed.
02
Drugs
tranexamic acid
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on 2012-000343-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000343-26.